Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

22nd Century Group Inc (XXII)

22nd Century Group Inc (XXII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

22nd Century Group Inc 321 Farmington Road Mocksville NC 27028 USA

www.xxiicentury.com P: 716-270-1523 F: 716-877-3064

Description:

22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.

Key Statistics

Overview:

Market Capitalization, $K 6,178
Enterprise Value, $K 18,028
Shares Outstanding, K 8,292
Annual Sales, $ 32,200 K
Annual Net Income, $ -140,780 K
Last Quarter Sales, $ 6,470 K
Last Quarter Net Income, $ -5,740 K
EBIT, $ -31,530 K
EBITDA, $ -26,670 K
60-Month Beta 1.38
% of Insider Shareholders 0.40%
% of Institutional Shareholders 18.06%
Float, K 8,259
% Float 99.60%
Short Volume Ratio 0.56

Growth:

1-Year Return -99.06%
3-Year Return -99.90%
5-Year Return -99.80%
5-Year Revenue Growth 21.83%
5-Year Earnings Growth -193.54%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.72 on 05/15/24
Next Earnings Date 08/12/24
Earnings Per Share ttm -47.16
EPS Growth vs. Prev Qtr 83.71%
EPS Growth vs. Prev Year 91.04%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-16 on 04/02/24

XXII Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -380.39%
Return-on-Assets % -104.60%
Profit Margin % -437.21%
Debt/Equity -1.27
Price/Sales 0.22
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -3.34
Interest Coverage -4.83
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar